Therapeutic cancer vaccine survives biotech bust.
Heidi
H
Ledford
D000818:Animals; D001709:Biotechnology / Q000191:economics*; D019496:Cancer Vaccines / Q000191:economics* / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation; D004345:Drug Industry / Q000191:economics*; D016520:Entrepreneurship / Q000191:economics; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000191:economics; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy; D014020:Tissue Extracts / Q000191:economics* / Q000627:therapeutic use
D019496:Cancer Vaccines; D014020:Tissue Extracts; C511774:sipuleucel-T